GLG Network Survey Tracker: API Supply and Manufacturing II

SURVEY DETAILS

TARGET POPULATION

GLG surveyed 60 senior executives working in pharmaceutical companies across the US and Europe (UK, France, Germany, Spain and Italy). This is the second iteration in this tracker series.

What will you learn from this survey?

• Respondents discussed the current scenario of sourcing products, the suppliers & distributors they are working with, and average inventory level most pharmaceutical companies normally keep for critical APIs.
• The survey also gathered insight into the approximate value of catalyst purchases per year and the countries where the experts are sourcing them from.
• Lastly, participants provided their views on the most important factors that influence their decision-making process for selecting suppliers.

Example of findings:

• Three-in-ten (30%) pharmaceuticals are currently working with Mylan which also is the API supplier with the most awareness (62%).
• Almost six-in-ten (58%) pharmaceuticals who buy catalysts spend less than $1M per year in catalysts, the proportion spending over $3M has decreased by more than half.
• Over half of respondents say price (65%) and regulatory / compliance (53%) are the most important factors when choosing a supplier, although regulatory / compliance lost some traction.

DELIVERABLES

The GLG Surveys team drafted the questionnaire with the support of GLG Network Member, Harmeet Lamba, former Vice President & Head (API’s & Niche Formulations) at Dr. Reddy’s Laboratories Limited.

The standard deliverable includes:

• 1 x Individual responses (“raw data”) in Excel.
• 1 x PPT report with aggregated data.
• Executive summary with key takeaways and highlights from the raw data.

SAMPLE QUESTIONS

• From your experience, on average, how many months inventory do companies in your sector normally keep for critical APIs?
• What is the approximate value of your catalyst purchases per year?
• Approximately, how many suppliers do you normally have for each product?
• Which of the following suppliers are you currently working with?
• How likely are your API suppliers to support you in case of an IP litigation?
• Which of the following distributors do you currently work with?
• Have prices changed in the last 12 months?

ACCESS

This survey is available to subscribers of the Healthcare (HC) sector (Limited subscriptions and above). This offer includes the raw data file and a high-level presentation through PowerPoint. Please contact your GLG representative for details on your firm’s access.

DISCLAIMER:

Please be advised that GLG Network Surveys operate differently than traditional GLG consultations, surveys, teleconferences, etc. and it is advisable that you consult with your firm’s legal and/or compliance department to review your use of the product and the payment for such work under your current subscription. 

By downloading this document and/or participating in the Network Survey, you understand and agree that the information and material provided by GLG, including survey results and survey proposal information, is provided for your own insight and informational purposes only. You further acknowledge and agree that this is a Network Survey for multiple GLG clients, and the results will be provided to all GLG clients that agree to participate in the Network Survey and GLG clients that agree to purchase the Survey results in the future. All survey results do not constitute investment advice or a recommendation. In using this Survey, you agree to hold Gerson Lehrman Group and the Survey respondents harmless and free of all liability as a result of your use of this Network Survey, other than liability resulting from the gross negligence or wilful misconduct of the protected party. You otherwise agree to be bound by Gerson Lehrman Group’s Usage Policies in your interactions with Gerson Lehrman Group and your receipt of services. These Survey results are for are for client’s own use and client shall not redistribute, disseminate, publish, or display the same, in whole or in part, to any third parties or publicly without the prior written permission of Gerson Lehrman Group, except explicitly set forth in your agreement with GLG. This survey will be double-blinded to both client and respondent. GLG reserves the right to restrict the number of clients that can pre-commit access. These Network Surveys are priced outside of standard GLG subscriptions but at a substantially reduced price to commissioning a fully proprietary GLG Network Survey. Upon finding these terms acceptable, please send an affirmative confirmation via email, which GLG will file in its records. Once confirmed, please note that the Client’s agreement to purchase the Network Survey is a legally binding and irrevocable commitment. If the survey is not included within your subscription, GLG will invoice Client for the fees due for the Network Survey. Please note that some respondents may not be Network Members, and the Terms and Conditions of Network Membership would not apply to such respondents and detailed records for them will not be available aside from the information that GLG capture in the Network Survey.